Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros

Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation of the earliest stages of lymphocyte ontogeny and differentiation. Functional deficiency of Ikaros has been implicated in the pathogenesis of acute lymphoblastic leukemia, the most common form of childhood cancer. Therefore, a stringent regulation of Ikaros activity is considered of paramount importance, but the operative molecular mechanisms responsible for its regulation remain largely unknown. Here we provide multifaceted genetic and biochemical evidence for a previously unknown function of spleen tyrosine kinase (SYK) as a partner and posttranslational regulator of Ikaros. We demonstrate that SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358 and S361, thereby augmenting its nuclear localization and sequence-specific DNA binding activity. Mechanistically, we establish that SYK-induced Ikaros activation is essential for its nuclear localization and optimal transcription factor function.

[1]  K. Shokat,et al.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates , 2012, Proceedings of the National Academy of Sciences.

[2]  J. Seavitt,et al.  Harnessing of the Nucleosome Remodeling Deacetylase complex controls lymphocyte development and prevents leukemogenesis , 2011, Nature Immunology.

[3]  Zanxian Xia,et al.  Functional analysis of novel phosphorylation sites of CREB‐binding protein using mass spectrometry and mammalian two‐hybrid assays , 2011, Proteomics.

[4]  Chunhua Song,et al.  Ikaros, CK2 kinase, and the road to leukemia , 2011, Molecular and Cellular Biochemistry.

[5]  M. A. Payne Zinc finger structure-function in Ikaros Marvin A Payne. , 2011, World journal of biological chemistry.

[6]  Rodrigo Orlandini de Castro,et al.  Regulation and Function of Syk Tyrosine Kinase in Mast Cell Signaling and Beyond , 2011, Journal of signal transduction.

[7]  R. Castro Regulation and function of syk tyrosine kinase in mast cell signaling and beyond. , 2011 .

[8]  Lionel O Mavoungou,et al.  Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation , 2011, Nucleic acids research.

[9]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[10]  M. Merkenschlager Ikaros in immune receptor signaling, lymphocyte differentiation, and function , 2010, FEBS letters.

[11]  F. Uckun,et al.  Targeting Human B-Precursor Acute Lymphoblastic Leukemia Cells with Recombinant Human CD19 Ligand , 2010 .

[12]  Geng Wu,et al.  ASD: a comprehensive database of allosteric proteins and modulators , 2010, Nucleic Acids Res..

[13]  M. Reth,et al.  Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor , 2010, Proceedings of the National Academy of Sciences.

[14]  F. Uckun,et al.  CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia , 2010, Proceedings of the National Academy of Sciences.

[15]  F. Uckun,et al.  Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas , 2010, Expert review of anticancer therapy.

[16]  M. Mandal,et al.  Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression , 2010, Molecular and Cellular Biology.

[17]  Victor L. J. Tybulewicz,et al.  The SYK tyrosine kinase: a crucial player in diverse biological functions , 2010, Nature Reviews Immunology.

[18]  F. Uckun,et al.  Targeting SYK kinase‐dependent anti‐apoptotic resistance pathway in B‐lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic , 2010, British journal of haematology.

[19]  S. Ng,et al.  Awakening lineage potential by Ikaros-mediated transcriptional priming. , 2010, Current opinion in immunology.

[20]  F. Uckun,et al.  Polo‐like‐kinase 1 (PLK1) as a molecular target to overcome SYK‐mediated resistance of B‐lineage acute lymphoblastic leukaemia cells to oxidative stress , 2010, British journal of haematology.

[21]  Hong Ma,et al.  STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress , 2010, Proceedings of the National Academy of Sciences.

[22]  Haizhen Zhong,et al.  Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. , 2009, Journal of molecular graphics & modelling.

[23]  E. Arias-Palomo,et al.  Conformational rearrangements upon Syk auto-phosphorylation. , 2009, Biochimica et biophysica acta.

[24]  K. Hung,et al.  Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1* , 2009, Journal of Biological Chemistry.

[25]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[26]  Emily K. Tsang,et al.  Molecular Mechanism of the Syk Activation Switch* , 2008, Journal of Biological Chemistry.

[27]  R. Månsson,et al.  E2A proteins promote development of lymphoid-primed multipotent progenitors. , 2008, Immunity.

[28]  J. Kuchar,et al.  Recruitment of Ikaros to Pericentromeric Heterochromatin Is Regulated by Phosphorylation* , 2008, Journal of Biological Chemistry.

[29]  John Kuriyan,et al.  Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70 , 2007, Cell.

[30]  A. Fisher,et al.  Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. , 2007, Immunity.

[31]  F. Uckun,et al.  Bruton's tyrosine kinase prevents activation of the anti‐apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B‐cells and B‐cell precursors exposed to oxidative stress , 2007, British journal of haematology.

[32]  Marietta L. Harrison,et al.  Nucleocytoplasmic Trafficking of the Syk Protein Tyrosine Kinase , 2006, Molecular and Cellular Biology.

[33]  S. Ng,et al.  Early hematopoietic lineage restrictions directed by Ikaros , 2006, Nature Immunology.

[34]  S. Reddy,et al.  Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. , 2005, Cancer research.

[35]  Stephen K Burley,et al.  A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase* , 2004, Journal of Biological Chemistry.

[36]  K. Georgopoulos,et al.  Phosphorylation Controls Ikaros's Ability To Negatively Regulate the G1-S Transition , 2004, Molecular and Cellular Biology.

[37]  Fatih M. Uckun,et al.  Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells* , 2001, The Journal of Biological Chemistry.

[38]  K. Sada,et al.  Structure and function of Syk protein-tyrosine kinase. , 2001, Journal of biochemistry.

[39]  F. Uckun,et al.  Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia , 2001, Oncogene.

[40]  A. Fisher,et al.  Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. , 2000, Genes & development.

[41]  H. Handa,et al.  The DNA-binding and transcriptional activities of MAZ, a myc-associated zinc finger protein, are regulated by casein kinase II. , 1999, Biochemical and biophysical research communications.

[42]  N. Heerema,et al.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Turner,et al.  Syk Tyrosine Kinase Is Required for the Positive Selection of Immature B Cells into the Recirculating B Cell Pool , 1997, The Journal of experimental medicine.

[44]  K. Georgopoulos,et al.  Zinc finger‐mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. , 1996, The EMBO journal.

[45]  T. Kurosaki,et al.  BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.

[46]  A. DeFranco B-cell co-receptors: The two-headed antigen , 1996, Current Biology.

[47]  R. Evans,et al.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Tony Pawson,et al.  Syk tyrosine kinase required for mouse viability and B-cell development , 1995, Nature.

[49]  K. Georgopoulos,et al.  The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins , 1994, Molecular and cellular biology.

[50]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[51]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[52]  A. Burkhardt,et al.  Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. , 1993, The Journal of biological chemistry.

[53]  D. Moore,et al.  Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. , 1992, Science.

[54]  S. Ralston,et al.  Analysis of transcriptional regulation in bone cells. , 2012, Methods in molecular biology.

[55]  V. Tybulewicz,et al.  CD19 is essential for B cell activation by promoting B cell receptor–antigen microcluster formation in response to membrane-bound ligand , 2008, Nature Immunology.

[56]  G. Koretzky,et al.  SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond , 2006, Nature Reviews Immunology.

[57]  A. DeFranco The two-headed antigen. B-cell co-receptors. , 1996, Current biology : CB.